Jana Medical Company (TADAWUL:9616)
Saudi Arabia
· Delayed Price · Currency is SAR
15.50
-0.04 (-0.26%)
Aug 14, 2025, 2:47 PM AST
Jana Medical Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 36.71 | 61.36 | 43.05 |
| Revenue Growth (YoY) | -40.18% | 42.55% | - |
| Cost of Revenue | 19.86 | 30.67 | 26.13 |
| Gross Profit | 16.84 | 30.69 | 16.92 |
| Selling, General & Admin | 13.95 | 14.99 | 8.77 |
| Operating Expenses | 22.09 | 18.16 | 9.41 |
| Operating Income | -5.24 | 12.53 | 7.5 |
| Interest Expense | -7.75 | -4.9 | -1.52 |
| Other Non Operating Income (Expenses) | -1.98 | -1.09 | -0.42 |
| EBT Excluding Unusual Items | -14.97 | 6.55 | 5.56 |
| Gain (Loss) on Sale of Assets | -0 | - | - |
| Legal Settlements | -6.78 | - | - |
| Pretax Income | -21.75 | 6.55 | 5.56 |
| Income Tax Expense | 1.42 | 1.13 | 0.34 |
| Net Income | -23.17 | 5.41 | 5.22 |
| Net Income to Common | -23.17 | 5.41 | 5.22 |
| Net Income Growth | - | 3.65% | - |
| Shares Outstanding (Basic) | 3 | 3 | 2 |
| Shares Outstanding (Diluted) | 3 | 3 | 2 |
| Shares Change (YoY) | 3.22% | 27.82% | - |
| EPS (Basic) | -8.74 | 2.11 | 2.60 |
| EPS (Diluted) | -8.74 | 2.11 | 2.60 |
| EPS Growth | - | -18.91% | - |
| Free Cash Flow | 5.32 | -12.78 | -36.77 |
| Free Cash Flow Per Share | 2.00 | -4.97 | -18.29 |
| Gross Margin | 45.89% | 50.02% | 39.30% |
| Operating Margin | -14.28% | 20.42% | 17.43% |
| Profit Margin | -63.13% | 8.82% | 12.14% |
| Free Cash Flow Margin | 14.48% | -20.82% | -85.42% |
| EBITDA | -5.1 | 12.66 | 7.56 |
| EBITDA Margin | -13.90% | 20.64% | 17.57% |
| D&A For EBITDA | 0.14 | 0.14 | 0.06 |
| EBIT | -5.24 | 12.53 | 7.5 |
| EBIT Margin | -14.28% | 20.42% | 17.43% |
| Effective Tax Rate | - | 17.27% | 6.07% |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.